Results 111 to 120 of about 2,801 (152)

Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity. [PDF]

Curr Opin Lipidol
Davidson MH, Hsieh A, Kastelein JJP.
europepmc   +1 more source

Effects of PCSK9 inhibitor evolocumab on preventing early neurological deterioration in acute ischemic stroke patients with or without large artery atherosclerosis: a subgroup analysis of a randomized trial. [PDF]

BMC Neurol
Liu J, Li Y, Tian W, Cao H, Li X, Cheng L, Ji X, Liu J.   +7 more
europepmc   +1 more source

Causal relationship between drug target genes of LDL-cholesterol and coronary artery disease: drug target Mendelian randomization study. [PDF]

Lipids Health Dis
Jee Y, Shin JW, Ryu M, Song TJ.
europepmc   +1 more source

Less intensive lipid-lowering therapy after ST-elevation myocardial infarction is associated with cardiovascular events: 2-year follow-up of "Jena auf Ziel". [PDF]

Clin Res Cardiol
Haertel F, Makhmudova U, Geiling JA, Lauer B, Möbius-Winkler S, Otto S, Schulze PC, Weingärtner O.   +7 more
europepmc   +1 more source

Cholesterol-Lowering Mechanism of <i>Lactobacillus</i> Bile Salt Hydrolase Through Regulation of <i>Bifidobacterium pseudolongum</i> in the Gut Microbiota. [PDF]

Nutrients
Liu Y, Kuang W, Li M, Wang Z, Liu Y, Zhao M, Huan H, Yang Y.   +7 more
europepmc   +1 more source

Role of Bailout Gene-Silencing Therapy in Plaque Lipid Reduction: Intravascular Imaging Study.

Cardiology
Kokina B, Trusinskis K, Kokina B, Lapsovs M, Karantajere M, Kanasniece E, Caunite L, Jegere S, Narbute I, Sondore D, Grave A, Kumsars I, Erglis A.   +12 more
europepmc   +1 more source

[Anticholesteremic agents and cholelithiasis].

Nihon rinsho. Japanese journal of clinical medicine, 1978
G, Kajiyama, T, Kawamoto, A, Maruhashi, A, Miyoshi   +3 more
openaire   +2 more sources

[Clinical evaluation of anticholesteremic agents].

Naika. Internal medicine, 1968
T, Kimura, H, Kudo
openaire   +2 more sources

[Arteriosclerosis with special reference to anticholesteremic agents].

Naika. Internal medicine, 1970
M, Murakami, H, Sekimoto, I, Nakada, T, Takegoshi, N, Iwaki   +4 more
openaire   +2 more sources

[Prevention of ischemic heart disease by changing diet and anticholesteremic agents. Risk hysteria or evidence-based work of physicians?].

Ugeskrift for laeger, 2000
S, Stender, A V, Astrup
openaire   +2 more sources